Published April 2005 | Version v1
Journal article

TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer

  • 1. Department of Experimental Clinical Oncology, Aarhus University Hospital (Denmark)
  • 2. Department of Radiation Oncology, University Hospital Mannheim (Germany)
  • 3. Clinical Trials and Statistics Unit, Section of Clinical Trials, Institute of Cancer Research, Sutton (United Kingdom)
  • 4. Gloucestershire Oncology Centre, Cheltenham (United Kingdom)
  • 5. Section of Radiotherapy, Institute of Cancer Research, Sutton (United Kingdom)

Description

Recent studies suggest that normal tissue radiosensitivity is influenced by single nucleotide polymorphisms (SNPs) in certain genes. In order to seek a confirmation of these findings, this study investigated SNPs in genes TGFB1 (position -509, codon 10 and codon 25), SOD2 (codon 16), XRCC1 (codon 399), XRCC3 (codon 241), APEX (codon 148) and ATM (codon 1853) in 26 breast cancer patients with marked changes in breast appearance after radiotherapy and 26 matched controls. Statistically significant associations were found between the TGFB1 codon 10 Pro allele (P=0.005) as well as the TGFB1 position -509 T allele (P=0.018) and increased risk of altered breast appearance. No significant associations were found for the remaining SNPs

Additional details

Identifiers

DOI
10.1016/j.radonc.2004.12.012;
PII
S0167-8140(04)00576-6;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
75
Journal Issue
1
Journal Page Range
p. 18-21
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
37018771
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; GENES; GROWTH FACTORS; HEALTH HAZARDS; MAMMARY GLANDS; NUCLEOTIDES; PATIENTS; RADIOSENSITIVITY; RADIOTHERAPY
Descriptors DEC
BODY; DISEASES; GLANDS; HAZARDS; MEDICINE; MITOGENS; NEOPLASMS; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANS; PROTEINS; RADIOLOGY; SENSITIVITY; THERAPY

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.